Partner Content
immune-system-1132182_1920 (1)
Partner Content

Understanding the evolving CAR-T market

In August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor T-cell (CAR-T) therapy.

Partner Content
59 Seconds Banner
Partner Content

Validating Your KOLs

Validating your KOLs for an evolving KOL landscape